Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002926709 | SCV003253710 | pathogenic | Fanconi anemia | 2022-08-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1565Profs*16) in the SLX4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLX4 are known to be pathogenic (PMID: 21240277). This variant is present in population databases (rs767572643, gnomAD 0.05%). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with SLX4-related conditions. |